NEW YORK, July 25 - Affymetrix has named Robert Ellis, who stepped down as CEO of Genometrix just before the company closed its doors June 25, to the position of vice president, product development and quality.
The company also announced that Barbara Caulfield would be the new vice president and general counsel, replacing Vern Norviel, who has become the new general counsel of subsidiary Perlegen.
Additionally, Gregory Schiffman will assume the role of chief financial officer beginning August 10, while current CFO Edward Hurwitz will take on a new role as senior vice president of corporate strategy and new ventures, the company said.
“This is a time of growth for Affymetrix and these management changes reflect our commitment to business expansion,” said Affymetrix CEO Stephen Fodor during the company’s second-quarter conference call.
In addition to his experience at Genometrix, of the Woodlands, Texas, Ellis has served as Applied Biosystems’ head of genetic analysis and nucleic acid synthesis, and was the company’s Far East vice president and general manager when Applied Biosystems was a division of Perkin Elmer. Ellis, who holds a B.A. from Hartwick College in New York, also worked for nine years in the scientific instrument division of Hewlett-Packard.
Caulfield joins Affymetrix from the law firm of Orrick, Herrington & Sutcliffe, where she was a partner and represented the company in its patent disputes with Incyte and Oxford Gene Technology. She has also represented Microsoft, Apple Computer, Mobil Oil, and Hoffman-LaRoche in patent disputes. She also formerly served as U.S. District Judge for the Northern District of California from 1991 until 1994.
Schiffman, who began working at Affymetrix earlier in the year as vice president of finance and administration, previously served vice president and controller of Applied Biosystems, and has 16 years of finance experience at Hewlett Packard and IBM.
Hurwitz, who has served as Affymetrix CFO since 1997, “ is taking on a new role in order to expand the opportunities for our technology and Affymetrix,” Fodor said.